Product Information

BUMETANIDE 0.5 MG TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.1356 per EA under NDC 16571067901. Its NADAC has been published 68 times since Mar 12, 2025.

BUMETANIDE 0.5 MG TABLET

bumetanide
$0.1356per EA

Strength

.5 mg/1

NDC

16571067901

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

6/17/2026

Active Ingredients

BUMETANIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA212019

On Market Since

6/3/2024

Pharmacological Classes

Increased Diuresis at Loop of Henle
Loop Diuretic

Price Statistics

The NADAC for BUMETANIDE 0.5 MG TABLET has been published 68 times since Mar 12, 2025, and over the history we have for it it has declined 4.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1356 per EA
All-time high$0.1658 (Jul 16, 2025)
All-time low$0.1265 (Feb 18, 2026)
52-week high$0.1658
52-week low$0.1265
Median price$0.1416
Average price$0.1444
Largest weekly change+13.3% (Mar 19, 2025)
Weeks tracked68
Tracking sinceMar 12, 2025

Price History

1W

0.0%

1M

+1.2%

3M

+6.5%

6M

+3.1%

1Y

-18.2%

3Y

N/A

5Y

N/A

All

-4.9%

Generic Alternatives

The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 7% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

Save up to 7%

1 alternative • Same active ingredient

Frequently asked questions

What is the NADAC price of BUMETANIDE 0.5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for BUMETANIDE 0.5 MG TABLET, manufactured by Rising Pharma Holdings Inc., is $0.1356 per EA (NDC 16571067901), effective Jun 24, 2026.

How has the price of BUMETANIDE 0.5 MG TABLET changed over time?

Over the history we have for it, the NADAC for BUMETANIDE 0.5 MG TABLET has declined 4.9%. It has been tracked across 68 weekly CMS publications since Mar 12, 2025.

What are the highest and lowest recorded NADAC prices for BUMETANIDE 0.5 MG TABLET?

Since Mar 12, 2025, the NADAC for BUMETANIDE 0.5 MG TABLET has ranged from a low of $0.1265 (Feb 18, 2026) to a high of $0.1658 (Jul 16, 2025), with a median of $0.1416 per EA.

Are there cheaper alternatives to BUMETANIDE 0.5 MG TABLET?

Yes. 1 NADAC-published product shares the same active ingredient, strength, and dosage form. The lowest-priced option, BUMETANIDE 0.5 MG TABLET, is $0.1265 per EA — about 7% below BUMETANIDE 0.5 MG TABLET.

Who manufactures BUMETANIDE 0.5 MG TABLET?

BUMETANIDE 0.5 MG TABLET (NDC 16571067901) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.